• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过孕妇病史、子宫动脉多普勒、平均动脉压和生化标志物联合筛查早发型和晚发型子痫前期及胎儿生长受限。

Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.

作者信息

Litwińska Ewelina, Litwińska Magdalena, Oszukowski Przemysław, Szaflik Krzysztof, Kaczmarek Piotr

机构信息

Perinatology and Gynecology Department, Polish Mother's Memorial Hospital Research Institute, Łódź, Poland.

Department of Gynecology, Fertility and Fetal Therapy, Polish Mother's Memorial Hospital Research Institute, Łódź, Poland.

出版信息

Adv Clin Exp Med. 2017 May-Jun;26(3):439-448. doi: 10.17219/acem/62214.

DOI:10.17219/acem/62214
PMID:28791818
Abstract

BACKGROUND

Pre-eclampsia is a systemic disease connected with high maternal and fetal morbidity and mortality. Despite significant progress achieved in perinatal medicine, pre-eclampsia is still one of the most significant current problems in obstetrics.

OBJECTIVES

The aim of the study was to establish diagnostic algorithms for early and late pre-eclampsia (PE) and intrauterine growth restriction (IUGR).

MATERIAL AND METHODS

A total of 320 pregnant women between 11 + 0 and 13 + 6 weeks of gestation were recruited for a case-control study. The study group consisted of 22 patients with early PE, 29 patients with late PE and 269 unaffected controls. The following parameters were recorded: maternal history, mean arterial pressure (MAP), mean uterine artery pulsatility index (UtA-PI), and the concentrations of placental growth factor (PlGF), pregnancy-associated plasma protein A (PAPP-A) and free beta-human chorionic gonadotropin (free β-hCG).

RESULTS

A multivariable stepwise logistic regression analysis indicated that the best screening model for the prediction of early PE is based on a combined analysis of maternal risk factors, UtA-PI and PlGF levels (sensitivity: 91%; specificity: 84%). The best screening model for the prediction of late PE is based on a combined analysis of maternal risk factors, UtA-PI and MAP (sensitivity: 85%; specificity: 83%). The most effective screening model for the prediction of IUGR is based on a combined analysis of maternal risk factors, UtA-PI and PlGF concentrations (sensitivity: 91%; specificity: 83%).

CONCLUSIONS

The integrated model of screening established in this study can be a valuable method to identify patients at increased risk of developing pre-eclampsia and related complications. The ability to predict the occurrence of pre-eclampsia in early pregnancy would enable maternal and fetal morbidity to be reduced through the introduction of strict obstetric surveillance as well as planned delivery in a reference center.

摘要

背景

子痫前期是一种与孕产妇和胎儿高发病率及死亡率相关的全身性疾病。尽管围产医学取得了显著进展,但子痫前期仍是当前产科最重要的问题之一。

目的

本研究的目的是建立早发型和晚发型子痫前期(PE)及胎儿生长受限(IUGR)的诊断算法。

材料与方法

共招募了320名妊娠11 + 0至13 + 6周的孕妇进行病例对照研究。研究组包括22例早发型PE患者、29例晚发型PE患者和269例未受影响的对照组。记录了以下参数:孕产妇病史、平均动脉压(MAP)、子宫动脉平均搏动指数(UtA-PI)以及胎盘生长因子(PlGF)、妊娠相关血浆蛋白A(PAPP-A)和游离β-人绒毛膜促性腺激素(游离β-hCG)的浓度。

结果

多变量逐步逻辑回归分析表明,预测早发型PE的最佳筛查模型基于孕产妇危险因素、UtA-PI和PlGF水平的综合分析(敏感性:91%;特异性:84%)。预测晚发型PE的最佳筛查模型基于孕产妇危险因素、UtA-PI和MAP的综合分析(敏感性:85%;特异性:83%)。预测IUGR最有效的筛查模型基于孕产妇危险因素、UtA-PI和PlGF浓度的综合分析(敏感性:91%;特异性:83%)。

结论

本研究建立的综合筛查模型可能是识别子痫前期及相关并发症发生风险增加患者的有价值方法。在妊娠早期预测子痫前期发生的能力将通过引入严格的产科监测以及在参考中心进行计划分娩来降低母婴发病率。

相似文献

1
Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers.通过孕妇病史、子宫动脉多普勒、平均动脉压和生化标志物联合筛查早发型和晚发型子痫前期及胎儿生长受限。
Adv Clin Exp Med. 2017 May-Jun;26(3):439-448. doi: 10.17219/acem/62214.
2
Screening for pre-eclampsia at 11-13 weeks' gestation: use of pregnancy-associated plasma protein-A, placental growth factor or both.11-13 孕周筛查子痫前期:使用妊娠相关血浆蛋白-A、胎盘生长因子或两者联合。
Ultrasound Obstet Gynecol. 2020 Sep;56(3):400-407. doi: 10.1002/uog.22093. Epub 2020 Aug 5.
3
Prediction of pre-eclampsia and its subtypes in high-risk cohort: hyperglycosylated human chorionic gonadotropin in multivariate models.多变量模型中,高风险队列中预测先兆子痫及其亚型:高糖基化人绒毛膜促性腺激素。
BMC Pregnancy Childbirth. 2018 Jul 3;18(1):279. doi: 10.1186/s12884-018-1908-9.
4
Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.小于胎龄儿的预测:孕30 - 34周时通过生物物理和生化标志物进行筛查。
Ultrasound Obstet Gynecol. 2015 Oct;46(4):446-51. doi: 10.1002/uog.14863. Epub 2015 Aug 6.
5
The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.国际妇产科联盟(FIGO)子痫前期倡议:早孕期筛查和预防的实用指南。
Int J Gynaecol Obstet. 2019 May;145 Suppl 1(Suppl 1):1-33. doi: 10.1002/ijgo.12802.
6
Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.血管生成因子和子宫动脉多普勒对早发型与晚发型子痫前期及胎儿生长受限的预测价值。
Ultrasound Obstet Gynecol. 2008 Mar;31(3):303-9. doi: 10.1002/uog.5184.
7
Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation.根据 11-13 孕周的母体因素和生物标志物,对双胎妊娠子痫前期进行筛查的竞争风险模型。
Ultrasound Obstet Gynecol. 2017 Nov;50(5):589-595. doi: 10.1002/uog.17531. Epub 2017 Sep 25.
8
Screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation.孕 11-13 周时通过母体因素和生物标志物筛查子痫前期。
Ultrasound Obstet Gynecol. 2018 Aug;52(2):186-195. doi: 10.1002/uog.19112. Epub 2018 Jul 11.
9
Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial.双胎妊娠中孕妇因素和生物标志物在 11-13 孕周预测子痫前期:EVENTS 试验数据。
Ultrasound Obstet Gynecol. 2021 Feb;57(2):257-265. doi: 10.1002/uog.23531.
10
Contingent screening for preterm pre-eclampsia.对早产先兆子痫进行有条件的筛查。
Ultrasound Obstet Gynecol. 2016 May;47(5):554-9. doi: 10.1002/uog.15807.

引用本文的文献

1
Personalized Model to Predict Small for Gestational Age at Delivery Using Fetal Biometrics, Maternal Characteristics, and Pregnancy Biomarkers: A Retrospective Cohort Study of Births Assisted at a Spanish Hospital.使用胎儿生物特征、母亲特征和妊娠生物标志物预测分娩时小于胎龄儿的个性化模型:一项对西班牙一家医院辅助分娩的回顾性队列研究。
J Pers Med. 2022 May 8;12(5):762. doi: 10.3390/jpm12050762.
2
Assessing the Role of Uric Acid as a Predictor of Preeclampsia.评估尿酸作为子痫前期预测指标的作用。
Front Physiol. 2022 Jan 13;12:785219. doi: 10.3389/fphys.2021.785219. eCollection 2021.
3
Unravelling the potential of angiogenic factors for the early prediction of preeclampsia.
揭示血管生成因子在子痫前期早期预测中的潜力。
Hypertens Res. 2021 Jul;44(7):756-769. doi: 10.1038/s41440-021-00647-9. Epub 2021 Apr 1.
4
Can Fetal Growth Velocity and First Trimester Maternal Biomarkers Improve the Prediction of Small-for-Gestational Age and Adverse Neonatal Outcome?胎儿生长速度和早孕期母体生物标志物能否改善小于胎龄儿和不良新生儿结局的预测?
Fetal Diagn Ther. 2019;46(4):274-284. doi: 10.1159/000499580. Epub 2019 May 8.